• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Sosei Group Corporation - Articles and news items

Heptares announces positive outcome of Phase 1a study of HTL9936

Industry news / 17 June 2015 / Victoria White

Heptares Therapeutics, the wholly-owned subsidiary of Sosei Group Corporation, has announced the positive outcome of its Phase 1a study with HTL9936…